Predicting drug loading in PLA-PEG nanoparticles

被引:44
|
作者
Meunier, M. [1 ]
Goupil, A. [2 ]
Lienard, P. [3 ]
机构
[1] Dassault Syst Biovia, 334 Milton Rd Sci Pk, Cambridge CB4 0WN, England
[2] Dassault Syst Biovia, 10 Rue Marcel Dassault, F-78140 Velizy Villacoublay, France
[3] Sanofi R&D, Pharmaceut Sci Dev, 13 Quai Jules Guesde, F-94400 Vitry Sur Seine, France
基金
欧盟地平线“2020”;
关键词
Drug delivery; Nanoparticles; Nanomedicine; Drug loading; Pharmaceutical development; Molecular dynamics; Solvation free energy; SOLUBILITY PARAMETERS; POLYMER MISCIBILITY; FORCE-FIELD; COEFFICIENTS; SIMULATION; MOLECULES; MIXTURES; DELIVERY;
D O I
10.1016/j.ijpharm.2017.04.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymer nanoparticles present advantageous physical and biopharmaceutical properties as drug delivery systems compared to conventional liquid formulations. Active pharmaceutical ingredients (APIs) are often hydrophobic, thus not soluble in conventional liquid delivery. Encapsulating the drugs in polymer nanoparticles can improve their pharmacological and bio-distribution properties, preventing rapid clearance from the bloodstream. Such nanoparticles are commonly made of non-toxic amphiphilic self assembling block copolymers where the core (poly-[D,L-lactic acid] or PLA) serves as a reservoir for the API and the external part (Poly-(Ethylene-Glycol) or PEG) serves as a stealth corona to avoid capture by macrophage. The present study aims to predict the drug affinity for PLA-PEG nanoparticles and their effective drug loading using in silico tools in order to virtually screen potential drugs for non-covalent encapsulation applications. To that end, different simulation methods such as molecular dynamics and Monte-Carlo have been used to estimate the binding of actives on model polymer surfaces. Initially, the methods and models are validated against a series of pigments molecules for which experimental data exist. The drug affinity for the core of the nanoparticles is estimated using a Monte-Carlo "docking" method. Drug miscibility in the polymer matrix, using the Hildebrand solubility parameter (delta), and the solvation free energy of the drug in the PLA polymer model is then estimated. Finally, existing published ALogP quantitative structure-property relationships (QSPR) are compared to this method. Our results demonstrate that adsorption energies modelled by docking atomistic simulations on PLA surfaces correlate well with experimental drug loadings, whereas simpler approaches based on Hildebrand solubility parameters and Flory-Huggins interaction parameters do not. More complex molecular dynamics techniques which use estimation of the solvation free energies both in PLA and in water led to satisfactory predictive models. In addition, experimental drug loadings and Log P are found to correlate well. This work can be used to improve the understanding of drug-polymer interactions, a key component to designing better delivery systems. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 50 条
  • [22] Solvent Effect in PLA-PEG Based Nanoparticles Synthesis through Surfactant Free Polymerization
    Ferrari, Raffaele
    Cingolani, Alberto
    Moscatelli, Davide
    MACROMOLECULAR SYMPOSIA, 2013, 324 (01) : 107 - 113
  • [23] Fabrication of PLA-PEG Nanoparticles as Delivery Systems for Improved Stability and Controlled Release of Catechin
    Singh, Neha Atulkumar
    Mandal, Abul Kalam Azad
    Khan, Zaved Ahmed
    JOURNAL OF NANOMATERIALS, 2017, 2017
  • [24] Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG Nanoparticles
    Gourdon, Betty
    Decleves, Xavier
    Pean, Jean-Manuel
    Chemin, Caroline
    PHARMACEUTICAL RESEARCH, 2018, 35 (04)
  • [25] Prolonged Release and Functionality of Interleukin-10 Encapsulated within PLA-PEG Nanoparticles
    Duncan, Skyla A.
    Dixit, Saurabh
    Sahu, Rajnish
    Martin, David
    Baganizi, Dieudonne R.
    Nyairo, Elijah
    Villinger, Francois
    Singh, Shree R.
    Dennis, Vida A.
    NANOMATERIALS, 2019, 9 (08)
  • [26] Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG Nanoparticles
    Betty Gourdon
    Xavier Declèves
    Jean-Manuel Péan
    Caroline Chemin
    Pharmaceutical Research, 2018, 35
  • [27] Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties
    Jelonek, Katarzyna
    Li, Suming
    Kaczmarczyk, Bozena
    Marcinkowski, Andrzej
    Orchel, Arkadiusz
    Musial-Kulik, Monika
    Kasperczyk, Janusz
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 510 (01) : 365 - 374
  • [28] Preparation and characterization of magnetic PLA-PEG composite particles
    Ren, J
    Hong, HY
    Ren, TB
    Teng, XR
    MATERIALS LETTERS, 2005, 59 (21) : 2655 - 2658
  • [29] Preparation, stability and cytocompatibility of magnetic/PLA-PEG hybrids
    Bakandritsos, Aristides
    Mattheolabakis, George
    Zboril, Radek
    Bouropoulos, Nikolaos
    Tucek, Jiri
    Fatouros, Dimitrios G.
    Avgoustakis, Konstantinos
    NANOSCALE, 2010, 2 (04) : 564 - 572
  • [30] PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
    Giacalone, Giovanna
    Tsapis, Nicolas
    Mousnier, Ludivine
    Chacun, Helene
    Fattal, Elias
    MATERIALS, 2018, 11 (10)